• Room 0G.008 - Pharmacy & MCI

    United Kingdom

Accepting PhD Students

PhD projects

Open to PhD applications in the field of ion channel modulation, proteases as potential biomarkers and therapeutics targets, infection and inflammation, chronic diseases, to include respiratory diseases and chronic wounds.

1994 …2025

Research activity per year

Personal profile

Interests

Lorraine Martin is a Professor of Biomolecular Sciences within the School of Pharmacy, Queen’s University Belfast. She holds a BSc and PhD in Biochemistry and a Masters in Clinical Laboratory Medicine. Her research interests are focussed on the role of active proteases as biomarkers and therapeutic targets in chronic airway diseases such as cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD), where aberrant activities due to a protease-antiprotease imbalance contribute to a vicious cycle of inflammation and impaired innate immunity. In this regard, the Martin Group at Queen’s have led a programme targeting proteases involved in the dysregulation of the epithelial sodium channel (ENaC), which leads to airways dehydration and mucus obstruction (Reihill et al, 2016, AJRCCM; Douglas et al, 2022 Cell Chem Biol; Douglas et al, 2024 ERJOR). In terms of a therapeutic strategy, inhibition of ENaC has the potential to rehydrate the airways to restore normal mucociliary clearance which would protect the airways from infection and irreversible tissue damage, stalling disease progression (Douglas et al, 2023 Eur Respir Rev).

Other recent achievements include a major interdisciplinary, collaborative, cross-border, €8.9M, 5-year project called BREATH (2017-22), whose goal was to build significant research capacity in COPD. BREATH stands for the Border and REgions Airways Training Hub and was funded by the INTERREG Va programme, managed by SEUPB (Special European Union Programmes Body). BREATH won the NI Healthcare Asthma/COPD Project of the Year Award (2018) and the QUB Vice-Chancellor's Excellence in Research Culture Prize (2020). Lorraine has also published >130 research publications and holds four patents. She has generated over £11M in research grant income to include BBSRC, MRC, Cystic Fibrosis (CF) Trust, the CF Foundation, USA, and Emily’s Entourage, USA and has productive research collaborations with UK industry and global pharma. She also has significant experience in entrepreneurship and innovation and was co-founder/CEO of QUB spin-out, ProAxsis Ltd. for which she won the INVENT competition (Catalyst Inc) (2013) and the Vice Chancellor's Prize for Research Impact (2016). She is a scientific advisor for several Irish and US-based companies, is the Innovation and Entrepreneurship Lead on the Queen’s Gender Initiative (QGI) Executive Committee, a Catalyst Role Model and sits on the University’s Research Innovation Committee. She also chairs the Post-doctoral Research Oversight Group. Within the School of Pharmacy, she is the Programme Director for the BSc in Pharmaceutical Biotechnology.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Fingerprint

Dive into the research topics where Lorraine Martin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or